Living Well with Cancer
This book uses solution-focused thinking to show how life with cancer may be lived well. Written in a chatty but powerfully effective style, it is for people who have cancer, their families, and friends, as well as the health professionals who seek to help them.
Public fear of breast cancer obscures the facts. Treatments can increase other health risks, while fear itself can impair quality of life. This book explores the history and mystery of breast cancer, from Ancient Egypt to the future, to champion the totality of women’s health.
This book highlights the usefulness of magnetic resonance imaging (MRI) for lung and thoracic tumors. Economical and with no radiation exposure, MRI offers advantages over CT and PET-CT, allowing for qualitative analysis of disease and early assessment of therapeutic effects.
The next generation of oncological hyperthermia selectively heats malignant cells. Due to its selectivity, this innovative concept is safer, less toxic, and uses significantly lower energy. This book shows the challenges, theoretical basis, and clinical results of the method.
Survival after Treatment for Gynaecological Cancer
As gynaecological cancer survival rates improve, quality of life after treatment is vital. This is the first textbook on managing the physical and psychological effects of treatment. It is essential reading for gynaecological oncology specialists and related disciplines.
This book provides a historical and applicable overview of current Interventional Oncology (IO) approaches. It explores treatment options, medical breakthroughs, and the disease processes themselves. This up-to-date review is crucial for learners and current interventionalists.
Learn how electrical pulses can make cancer treatment more efficient with fewer side effects. Successfully used with chemotherapy on over 3000 patients, this method doesn’t require high-tech resources, making it ideal for less-equipped healthcare settings.
This book describes the latest knowledge on hereditary colorectal cancer syndromes, focusing on management, surveillance, and screening. It discusses multidisciplinary care, risk estimation, genetic information, and future developments in this evolving field.
On the Forefront of Hematology and Oncology
From a clinical pharmacist specializing in oncology, this book illuminates the fundamental aspects of solid and blood cancers and their novel drug therapies. Emphasizing key concepts, it provides a clear introduction for clinicians and students to understand oncology principles.
This volume covers cancer epidemiology, drug development, and therapies, presenting tools to assess side effects. It also explores patient quality of life, palliative care, and the global disparities that prevent equal access to diagnosis and treatment.
Molecular Biomarkers in Cancer
This book covers the history of cancer research and the evolution of techniques for its diagnosis and treatment. It explores key developments from genetics and omics to modern approaches using microRNA, novel sequencing, and machine learning.
Explore the latest findings on the tumor molecular microenvironment’s role in cancer progression. This book highlights new therapeutic targets based on apoptosis, autophagy, and tumor signaling, and reveals how nanoformulations are revolutionizing the future of cancer therapy.
The treatment of cancer patients must include quality of life. As this book shows, patients do not have equal access to cancer treatment around the world, and often basic diagnosis and treatment are lacking.
For patients with metastatic cancer, the prognosis remains grim and conventional chemotherapy is limited. This book lays out a novel strategy using artificial intelligence and genomic data to develop precise, personalized treatments that offer hope for an eventual cure.
This book uses a systems biology approach to understand complex cancers. It analyzes cellular networks to identify key biomarkers for drug targets, and presents the design of a multiple-molecule drug for therapeutic treatment with fewer side effects.
This thorough study of radio-pathological correlation in breast cancer offers a pathology of the disease and 35 practical case studies. It is an essential resource for breast clinicians, pathologists, and students.
In the quest for a ‘magic bullet’ against cancer, nanoparticles show great promise. These engineered nanostructures can target specific tumors, but their effectiveness must be weighed against toxicity. This book explores diverse nanotechnological advances.
Rare Tumours of the Kidney
Rare malignant neoplasms of the kidney have aggressive outcomes but are not covered in most books of Urology, Surgery, and Medicine. This book focuses on these rare neoplasms, providing updated information on a heterogeneous group of disorders with distinct abnormalities.
Rare types of prostate cancer are aggressive, have poor prognoses, and are often misdiagnosed. This book updates the literature on these rare neoplasms to alert clinicians and encourage research to find more effective treatment options.
Rare prostate cancers have an aggressive biological behaviour and inferior prognosis, often due to delayed or incorrect diagnosis. This book updates the literature on rare neoplasms of the prostate to help speed up diagnosis and treatment and encourage research into new options.